Funding source: Natural Science Foundation of Hebei Province of China
Award Identifier / Grant number: H20200206349
Funding source: Research Fund of Students Innovative Experimental Project of Hebei Medical University of China
Award Identifier / Grant number: 2019041
-
Research funding: This work was supported by the Grant of Natural Science Foundation of Hebei Province of China [H20200206349] and the Research Fund of Students Innovative Experimental Project of Hebei Medical University of China [2019041].
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The research complies with all relevant national regulations and institutional policies and has been approved by the ethics review committees at The Second Hospital of Hebei Medical University, China [certificate no. 2020-R311].
References
1. Bury, L, Megy, K, Stephens, JC, Grassi, L, Greene, D, Gleadall, N, et al.. Next‐generation sequencing for the diagnosis of MYH9‐RD: predicting pathogenic variants. Hum Mutat 2020;41:277–90. https://doi.org/10.1002/humu.23927.Search in Google Scholar PubMed PubMed Central
2. Pecci, A, Klersy, C, Gresele, P, Lee, KJ, De Rocco, D, Bozzi, V, et al.. MYH9‐related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype–phenotype correlations. Hum Mutat 2014;35:236–47. https://doi.org/10.1002/humu.22476.Search in Google Scholar PubMed PubMed Central
3. Noris, P, Balduini, CL. Inherited thrombocytopenias in the era of personalized medicine. Haematologica 2015;100:145–8. https://doi.org/10.3324/haematol.2014.122549.Search in Google Scholar PubMed PubMed Central
4. Rabbolini, DJ, Chun, Y, Latimer, M, Kunishima, S, Fixter, K, Valecha, B, et al.. Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia. Platelets 2018;29:793–800. https://doi.org/10.1080/09537104.2017.1356920.Search in Google Scholar PubMed
5. Zhang, Y, Conti, MA, Malide, D, Dong, F, Wang, A, Shmist, YA, et al.. Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A. Blood 2012;119:238–50. https://doi.org/10.1182/blood-2011-06-358853.Search in Google Scholar PubMed PubMed Central
6. Saposnik, B, Binard, S, Fenneteau, O, Nurden, A, Nurden, P, Hurtaud-Roux, MF, et al.. French MYH9 networka. Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders. Mol Genet Genomic Med 2014;2:297–312. https://doi.org/10.1002/mgg3.68.Search in Google Scholar PubMed PubMed Central
7. Kitamura, K, Yoshida, K, Shiraishi, Y, Chiba, K, Tanaka, H, Furukawa, K, et al.. Normal neutrophil myosin IIA localization in an immunofluorescence analysis can rule out MYH9 disorders. J Thromb Haemost 2013;11:2071–3. https://doi.org/10.1111/jth.12406.Search in Google Scholar PubMed
8. Pecci, A, Ma, X, Savoia, A, Adelstein, RS. MYH9: structure, functions and role of non-muscle myosin ⅡA in human disease. Gene 2018;664:152–67. https://doi.org/10.1016/j.gene.2018.04.048.Search in Google Scholar PubMed PubMed Central
9. Spinler, KR, Shin, JW, Lambert, MP, Discher, DE. Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia. Blood 2015;125:525–33. https://doi.org/10.1182/blood-2014-05-576462.Search in Google Scholar PubMed PubMed Central
10. Pecci, A, Verver, EJ, Schlegel, N, Canzi, P, Boccio, CM, Platokoukiet, H, et al.. Cochlear implantation is safe and effective in patients with MYH9-related disease. Orphanet J Rare Dis 2014;9:100. https://doi.org/10.1186/1750-1172-9-100.Search in Google Scholar PubMed PubMed Central
11. Canzi, P, Pecci, A, Manfrin, M, Rebecchi, E, Zaninetti, C, Bozzi, V, et al.. Severe to profound deafness may be associated with MYH9-related disease: report of 4 patients. Acta Otorhinolaryngol Ital 2016;36:415–20. https://doi.org/10.14639/0392-100x-702.Search in Google Scholar
12. Pecci, A, Biino, G, Fierro, T, Bozzi, V, Mezzasoma, A, Noris, P, et al.. Alteration of liver enzymes is a feature of the MYH9-related disease syndrome. PLoS One 2012;7:e35986. https://doi.org/10.1371/journal.pone.0035986.Search in Google Scholar PubMed PubMed Central
© 2021 Walter de Gruyter GmbH, Berlin/Boston
